MASIMO CORPORATION (NASDAQ:MASI) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
Results of Operations and Financial Condition.
On August2, 2017, Masimo Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended July1, 2017. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
|
Item 9.01. |
Financial Statements and Exhibits. |
(d) The following item is filed as an exhibit to the Current Report on Form 8-K.
|
Exhibit No. |
Description |
|
99.1 |
Press Release, dated August 2, 2017, Reporting Second Quarter 2017 Financial Results |
MASIMO CORP ExhibitEX-99.1 2 masi-20170802xex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Masimo Reports Second Quarter 2017 Financial ResultsQ2 2017 Highlights (compared to Q2 2016): ■ Total revenue,…To view the full exhibit click here
About MASIMO CORPORATION (NASDAQ:MASI)
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.
